menu
    • menu

    Company profile for Aptevo Therapeutics

    NEW Drugs in Dev: 10
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a resul...
    Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, etc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aptevo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2401 4th Avenue, Suite 1050 Seattle, WA 98121
    Telephone
    Telephone
    206-838-0500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aptevotherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aptevo Appoints Mary Janatpour as Chief Scientific Officer
    Aptevo Appoints Mary Janatpour as Chief Scientific Officer

    28 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-28/aptevo-therapeutics-appoints-mary-j-janatpour-phd-as-senior-vice-president-chief-scientific-o

    PHARMIWEB
    28 May 2026
    Share Share
    Aptevo, Niowave Collaborate on Strategic Equity Investment
    Aptevo, Niowave Collaborate on Strategic Equity Investment

    27 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-27/aptevo-and-niowave-launch-strategic-collaboration-for-radiopharmaceutical-therapeutic-development-i

    PHARMIWEB
    27 May 2026
    Share Share
    Aptevo Says RAINIER Study Remains on Track
    Aptevo Says RAINIER Study Remains on Track

    13 May 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/aptevo-therapeutics-provides-a-1q26-business-update-rainier-on-track-1166364

    ACCESSWIRE
    13 May 2026
    Share Share
    Aptevo Reports 87% Clinical Benefit in Frontline AML
    Aptevo Reports 87% Clinical Benefit in Frontline AML

    06 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-06/aptevo-reports-87-clinical-benefit-and-81-remission-in-31-evaluable-frontline-aml-patients-through

    PHARMIWEB
    06 May 2026
    Share Share
    Aptevo Releases 2025 Financial Results And Business Update
    Aptevo Releases 2025 Financial Results And Business Update

    26 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-26/aptevo-provides-state-of-the-business-report-and-2025-financial-results

    PHARMIWEB
    26 Mar 2026
    Share Share
    Aptevo to Participate in March 2026 Conferences
    Aptevo to Participate in March 2026 Conferences

    19 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-19/aptevo-to-participate-in-march-2026-conferences

    PHARMIWEB
    19 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search